Skip to main content

Animations

MJFF Publications

4481 - 4490 of 6515 Results
Title
Year
  • Year
  • 2021
  • 2023
  • 2023
  • 2022
  • 2013
  • 2016
  • 2024
  • 2020
  • 2020
  • 2020
  • Summary Details
    OPEN
    Title: Thalamic Dorsomedial Nucleus Free Water Correlates with Cognitive Decline in Parkinson's Disease
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28886
    Citation Count: 20
  • Summary Details
    OPEN
    Title: Cholinergic Nucleus 4 Degeneration and Cognitive Impairment in Isolated Rapid Eye Movement Sleep Behavior Disorder
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mds.29306
    Citation Count: 21
  • Summary Details
    OPEN
    Title: Urinary incontinence‐related effects on functional connectivity circuits in persons with Parkinson's disease
    Journal Name: Neurourology and Urodynamics
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/nau.25258
    Citation Count: 3
  • Summary Details
    OPEN
    Title: Validation of an automatic tool for the rapid measurement of brain atrophy and white matter hyperintensity: QyScore®
    Journal Name: European Radiology
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1007/s00330-021-08385-9
    Citation Count: 19
  • Summary Details
    OPEN
    Title: CSF α-synuclein improves diagnostic and prognostic performance of CSF tau and Aβ in Alzheimer’s disease
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-013-1148-z
    Citation Count: 112
  • Summary Details
    OPEN
    Title: CSF biomarkers associated with disease heterogeneity in early Parkinson’s disease: the Parkinson’s Progression Markers Initiative study
    Journal Name: Acta Neuropathologica
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s00401-016-1552-2
    Citation Count: 215
  • Summary Details
    OPEN
    Title: Characterizing enteric neurons in dopamine transporter (DAT)‐Cre reporter mice reveals dopaminergic subtypes with dual‐transmitter content
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1111/ejn.16307
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Neuropsychiatric symptoms and cognitive abilities over the initial quinquennium of Parkinson disease
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51022
    Citation Count: 83
  • Summary Details
    OPEN
    Title: Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51164
    Citation Count: 40
  • Summary Details
    OPEN
    Title: Dopamine transporter imaging predicts clinically‐defined α‐synucleinopathy in REM sleep behavior disorder
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd, cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51269
    Citation Count: 60
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.